Innovent Biologics Competitors and Similar CompaniesClear all
Innovent Biologics's competitors and similar companies include Roivant Sciences, Sanofi Genzyme, Gero and Disc Medicine.
 Innovent Biologics Innovent Biologics is a biopharmaceutical company developing and manufacturing monoclonal antibodies. |  Sanofi Genzyme Sanofi Genzyme (also known as Genzyme Corporation) is a biotech company that specializes in rare diseases, rare blood disorders, multiple sclerosis, oncology, and immunology. |  Gero Gero is a biotechnology company intended to evaluate the personal risks of mortality and health. |  Disc Medicine Disc Medicine (formerly known as Gemini Therapeutics) is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of treatments for patients suffering from hematologic diseases.
| ||
Founding Date | Founding Date 2011 | Founding Date 2014 | Founding Date 1981 | Founding Date 2015 | Founding Date 2017 |
Type | Type Private | Type Public | Type Subsidiary | Type Private | Type Public |
Tags | |||||
Locations | Locations Fangshan Qu, CN HQ | Locations London, GB HQ Basel, CH Boston, US New York, US | Locations Cambridge, US HQ Macquarie Park, AU Malaga, AU Virginia, AU São Paulo, BR Mississauga, CA Toronto, CA see more | Locations Singapore, SG HQ Agios Athanasios, CY Moskva, RU | Locations Watertown, US HQ |
Employees | Employees 831 | Employees 908 | Employees 9,9041% decrease | Employees 105 | Employees 15585% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 8.8 b | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 1.4 b |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $8.3m (FY, 2025) | Revenue (est.) €10.4b (FY, 2019) | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income N/A | Net income ($397.9m) (FY, 2025) | Net income N/A | Net income N/A | Net income ($212.2m) (FY, 2025) |
Funding | |||||
Latest funding round | Latest funding round $ 150m (about 8 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 2.2m (almost 6 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 560m | Total funding raised $ 1.9b | Total funding raised N/A | Total funding raised $ 7.5m | Total funding raised $ 50m |
For sources of this data, please see the company profile
View Company Profiles
Roivant Sciences
HQ
London, GB
Employees
908
Roivant Sciences is a company that develops and commercializes medicines.
View companySanofi Genzyme
HQ
Cambridge, US
Sanofi Genzyme (also known as Genzyme Corporation) is a biotech company that specializes in rare diseases, rare blood disorders, multiple sclerosis, oncology, and immunology.
View companyGero
HQ
Singapore, SG
Employees
105
Gero is a biotechnology company intended to evaluate the personal risks of mortality and health.
View companyDisc Medicine
HQ
Watertown, US
Employees
155
Disc Medicine (formerly known as Gemini Therapeutics) is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of treatments for patients suffering from hematologic diseases.
View company